Rodolphe Beaud, Hydroarylation régiosélective d’indoles pour l’accès aux motifs 3 - arylindolines : études et applications d’une nouvelle réactivité de l’indole, Institut de Chimie Moléculaire et des Matériaux d'Orsay, Université Paris-Sud, (HALtel-01127058, présentation en ligne, lire en ligne [PDF]), p. 28.
aspetjournals.org
jpet.aspetjournals.org
(en) Pilar Alarma-Estrany, Ana Guzman-Aranguez, Fernando Huete, Assumpta Peral, Robert Plourde Jr, Teresa Pelaez, Benjamin Yerxa et Jesús Pintor, « Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits », The Journal of Pharmacology and Experimental Therapeutics, vol. 337, no 3, , p. 703-709 (résumé).
cmbl.org.pl
(en) Akcay YD, Yalcin A, Sozmen EY, « The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid-induced injury », Cell. Mol. Biol. Lett., vol. 10, no 2, , p. 321–9 (PMID16010296, lire en ligne [PDF]).
cnrs.fr
www2.cnrs.fr
Étude conduite par Philippe Froguel (laboratoire Génomique et physiologie moléculaire des maladies métaboliques ; CNRS/ Université Lille 2 Droit et Santé/ Institut Pasteur de Lille) et l'Imperial College London, en collaboration avec des équipes françaises, finlandaises et danoises, sur la base de l'analyse du génome de 23 000 personnes, publiée dans Nature Genetics en décembre 2008 (A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risks. N. Bouatia-Naji et al. ; Nature Genetics, numéro 41, pages 89–94, 2009, https://doi.org/10.1038/ng.277 ). Les résultats de cette étude ont été confirmés par deux autres études internationales publiées au même moment (CNRS).
Paolo Lissoni, Franco Rovelli, Fernando Brivio, Giusy Messina, Arianna Lissoni, Sonja Pensato et Giuseppe Di Fede, « Five Year-Survival with High-Dose Melatonin and Other Antitumor Pineal
Hormones in Advanced Cancer Patients Eligible for the Only Palliative Therapy », Research Journal of Oncology, vol. 2, no 1: 2, (lire en ligne [PDF])
Alejandro Ibáñez-Costa, José Córdoba-Chacón, Manuel D. Gahete et Rhonda D. Kineman, « Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates », Endocrinology, vol. 156, no 3, , p. 1100–1110 (ISSN1945-7170, PMID25545385, PMCID4330310, DOI10.1210/en.2014-1819, lire en ligne, consulté le )
(en) José Cipolla-Neto et Fernanda Gaspar do Amaral, « Melatonin as a Hormone: New Physiological and Clinical Insights », Endocrine Reviews, vol. 39, no 6, , p. 990–1028 (ISSN0163-769X et 1945-7189, DOI10.1210/er.2018-00084, lire en ligne, consulté le )
(en) José Cipolla-Neto, Fernanda Gaspar Amaral, José Maria Soares, Jr et Camila Congentino Gallo, « The Crosstalk between Melatonin and Sex Steroid Hormones », Neuroendocrinology, vol. 112, no 2, , p. 115–129 (ISSN0028-3835 et 1423-0194, DOI10.1159/000516148, lire en ligne, consulté le )
(en) Hardeland R, « Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance », Endocrine, vol. 27, no 2, , p. 119–30. (PMID16217125, DOI10.1385/ENDO:27:2:119)
Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S, « Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system », Ann NY Acad Sci, vol. 939, , p. 200–15. (PMID11462772, DOI10.1111/j.1749-6632.2001.tb03627.x, Bibcode2001NYASA.939..200R)
Antonio Carrillo-Vico, Juan M. Guerrero, Patricia J. Lardone et Russel J. Reiter, « A review of the multiple actions of melatonin on the immune system », Endocrine, vol. 27, no 2, , p. 189–200 (ISSN1355-008X, PMID16217132, DOI10.1385/ENDO:27:2:189, lire en ligne, consulté le )
(en) Feixiong Cheng, « A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 », PLOS Biology, vol. 18, no 11, , e3000970 (ISSN1545-7885, DOI10.1371/journal.pbio.3000970, lire en ligne, consulté le ).
(en) Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ, « Phytomelatonin: a review », J Exp Bot, vol. 60, no 1, , p. 57–69 (PMID19033551, DOI10.1093/jxb/ern284)
A. Lerchl et S. Schlatt, « Serotonin content and melatonin production in the pineal gland of the male Djungarian hamster (Phodopus sungorus) », Journal of Pineal Research, vol. 12, no 3, , p. 128–134 (ISSN0742-3098, PMID1380550, DOI10.1111/j.1600-079x.1992.tb00039.x, lire en ligne, consulté le )
(en) Carmen Venegas, José A. García, Germaine Escames et Francisco Ortiz, « Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations: Brain and liver extrapineal melatonin distribution », Journal of Pineal Research, vol. 52, no 2, , p. 217–227 (DOI10.1111/j.1600-079X.2011.00931.x, lire en ligne, consulté le )
Yalikun Suofu, Wei Li, Frédéric G. Jean-Alphonse et Jiaoying Jia, « Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release », Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no 38, , E7997–E8006 (ISSN0027-8424, PMID28874589, PMCID5617277, DOI10.1073/pnas.1705768114, lire en ligne, consulté le )
Russel J. Reiter, Dun Xian Tan, Sergio Rosales-Corral et Annia Galano, « Mitochondria: Central Organelles for Melatonin′s Antioxidant and Anti-Aging Actions », Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, vol. 23, no 2, , p. 509 (ISSN1420-3049, PMID29495303, PMCID6017324, DOI10.3390/molecules23020509, lire en ligne, consulté le )
(en) Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ, « Phytomelatonin : a review », J. Exp. Bot., vol. 60, no 1, , p. 57–69 (PMID19033551, DOI10.1093/jxb/ern284, lire en ligne).
Garth R. Swanson, Annika Gorenz, Maliha Shaikh et Vishal Desai, « Decreased melatonin secretion is associated with increased intestinal permeability and marker of endotoxemia in alcoholics », American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 308, no 12, , G1004–G1011 (ISSN0193-1857, PMID25907689, PMCID4469868, DOI10.1152/ajpgi.00002.2015, lire en ligne, consulté le )
Young Sook Park, Soo Hyung Kim, Jong Won Park et Younglim Kho, « Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation », Intestinal Research, vol. 18, no 3, , p. 325–336 (ISSN1598-9100, PMID32564539, PMCID7385569, DOI10.5217/ir.2019.00093, lire en ligne, consulté le )
(en) Andries Kalsbeek et al. (2000), « Melatonin sees the light: blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin » European Journal of Neuroscience vol. 12, no 9, pages 3146–3154, septembre 2000 ; DOI10.1046/j.1460-9568.2000.00202.x (résumé)
Vennila Suriagandhi et Vasanthi Nachiappan, « Protective Effects of Melatonin against Obesity-Induced by Leptin Resistance », Behavioural Brain Research, vol. 417, , p. 113598 (ISSN1872-7549, PMID34563600, DOI10.1016/j.bbr.2021.113598, lire en ligne, consulté le )
Pilar Cano, Daniel P. Cardinali, María J. Ríos-Lugo et María P. Fernández-Mateos, « Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats », Obesity (Silver Spring, Md.), vol. 17, no 10, , p. 1866–1871 (ISSN1930-7381, PMID19543212, DOI10.1038/oby.2009.200, lire en ligne, consulté le )
Angeliki Karamitri, Nicolas Renault, Nathalie Clement et Jean-Luc Guillaume, « Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes », Molecular Endocrinology (Baltimore, Md.), vol. 27, no 8, , p. 1217–1233 (ISSN1944-9917, PMID23798576, PMCID5427945, DOI10.1210/me.2013-1101, lire en ligne, consulté le )
Alan Hegron et Ralf Jockers, « Analyse approfondie du lien entre le récepteur MT2 de la mélatonine et le diabète de type 2 », médecine/sciences, vol. 35, no 5, , p. 412–416 (ISSN0767-0974 et 1958-5381, DOI10.1051/medsci/2019088, lire en ligne, consulté le )
(en) Dun-Xian Tan, Lucien C. Manchester, Maria P. Terron et Luis J. Flores, « One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species? », Journal of Pineal Research, vol. 42, no 1, , p. 28–42 (ISSN0742-3098 et 1600-079X, DOI10.1111/j.1600-079X.2006.00407.x, lire en ligne, consulté le )
Jerry Vriend et Russel J. Reiter, « The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome », Molecular and Cellular Endocrinology, vol. 401, , p. 213–220 (ISSN1872-8057, PMID25528518, DOI10.1016/j.mce.2014.12.013, lire en ligne, consulté le )
(en) Russel J. Reiter, L.C. Manchester et Dun-xian Tan, « Melatonin in walnuts: Influence on levels of melatonin and total antioxidant capacity of blood », Nutrition, vol. 21, no 9, , p. 920–924 (DOI10.1016/j.nut.2005.02.005, lire en ligne, consulté le )
(en) Juan R. Calvo, C. González-Yanes et M. D. Maldonado, « The role of melatonin in the cells of the innate immunity: a review », Journal of Pineal Research, vol. 55, no 2, , p. 103–120 (DOI10.1111/jpi.12075, lire en ligne, consulté le )
FA. Scheer, CJ. Morris, JI. Garcia, C. Smales, EE. Kelly, J. Marks, A. Malhotra et SA. Shea, « Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. », Sleep, vol. 35, no 10, , p. 1395-402 (PMID23024438, DOI10.5665/sleep.2122)
K. P. Wright, B. L. Myers, S. C. Plenzler et C. L. Drake, « Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives », Brain Research, vol. 873, no 2, , p. 310–317 (ISSN0006-8993, PMID10930561, DOI10.1016/s0006-8993(00)02557-9, lire en ligne, consulté le )
Kathleen E. West, Michael R. Jablonski, Benjamin Warfield et Kate S. Cecil, « Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans », Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 110, no 3, , p. 619–626 (ISSN1522-1601, PMID21164152, DOI10.1152/japplphysiol.01413.2009, lire en ligne, consulté le )
Mariana G. Figueiro et Mark S. Rea, « The Effects of Red and Blue Lights on Circadian Variations in Cortisol, Alpha Amylase, and Melatonin », International Journal of Endocrinology, vol. 2010, , p. 829351 (ISSN1687-8337, PMID20652045, PMCID2905913, DOI10.1155/2010/829351, lire en ligne, consulté le )
Olga Pechanova, Ludovit Paulis et Fedor Simko, « Peripheral and central effects of melatonin on blood pressure regulation », International Journal of Molecular Sciences, vol. 15, no 10, , p. 17920–17937 (ISSN1422-0067, PMID25299692, PMCID4227197, DOI10.3390/ijms151017920, lire en ligne, consulté le )
Huanshuai Guan, Ning Kong, Run Tian et Ruomu Cao, « Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis », Journal of Translational Medicine, vol. 20, no 1, , p. 132 (ISSN1479-5876, PMID35296324, PMCID8925213, DOI10.1186/s12967-022-03341-7, lire en ligne, consulté le )
Tian Li, Shuai Jiang, Chenxi Lu et Wenwen Yang, « Melatonin: Another avenue for treating osteoporosis? », Journal of Pineal Research, vol. 66, no 2, , e12548 (ISSN1600-079X, PMID30597617, DOI10.1111/jpi.12548, lire en ligne, consulté le )
Fahima Munmun et Paula A. Witt-Enderby, « Melatonin effects on bone: Implications for use as a therapy for managing bone loss », Journal of Pineal Research, vol. 71, no 1, , e12749 (ISSN1600-079X, PMID34085304, DOI10.1111/jpi.12749, lire en ligne, consulté le )
José Carlos Pereira, Márcia Pradella Hallinan et Rosana Cardoso Alves, « Secondary to excessive melatonin synthesis, the consumption of tryptophan from outside the blood-brain barrier and melatonin over-signaling in the pars tuberalis may be central to the pathophysiology of winter depression », Medical Hypotheses, vol. 98, , p. 69–75 (ISSN1532-2777, PMID28012610, DOI10.1016/j.mehy.2016.11.020, lire en ligne, consulté le )
Maria E. J. Bouwmans, Elisabeth H. Bos, Sanne H. Booij et Martijn van Faassen, « Intra- and inter-individual variability of longitudinal daytime melatonin secretion patterns in depressed and non-depressed individuals », Chronobiology International, vol. 32, no 3, , p. 441–446 (ISSN1525-6073, PMID25347155, DOI10.3109/07420528.2014.973114, lire en ligne, consulté le )
Barbara Nussbaumer-Streit, Amy Greenblatt, Angela Kaminski-Hartenthaler et Megan G. Van Noord, « Melatonin and agomelatine for preventing seasonal affective disorder », The Cochrane Database of Systematic Reviews, vol. 6, no 6, , p. CD011271 (ISSN1469-493X, PMID31206585, PMCID6578031, DOI10.1002/14651858.CD011271.pub3, lire en ligne, consulté le )
(en) Maria D. Maldonado, Russel J. Reiter et Maria A. Pérez-San-Gregorio, « Melatonin as a potential therapeutic agent in psychiatric illness », Human Psychopharmacology: Clinical and Experimental, vol. 24, no 5, , p. 391–400 (ISSN1099-1077, DOI10.1002/hup.1032, lire en ligne, consulté le )
George Anderson et Michael Maes, « Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects », Metabolic Brain Disease, vol. 27, no 2, , p. 113–119 (ISSN1573-7365, PMID22527998, DOI10.1007/s11011-012-9307-9, lire en ligne, consulté le )
Yunho Jin, Jeonghyun Choi, Seunghoon Lee et Jong Won Kim, « Pathogenetical and Neurophysiological Features of Patients with Autism Spectrum Disorder: Phenomena and Diagnoses », Journal of Clinical Medicine, vol. 8, no 10, , p. 1588 (ISSN2077-0383, PMID31581672, PMCID6832208, DOI10.3390/jcm8101588, lire en ligne, consulté le )
M. L. Rao, B. Müller-Oerlinghausen, A. Mackert et B. Strebel, « Blood serotonin, serum melatonin and light therapy in healthy subjects and in patients with nonseasonal depression », Acta Psychiatrica Scandinavica, vol. 86, no 2, , p. 127–132 (ISSN0001-690X, PMID1529735, DOI10.1111/j.1600-0447.1992.tb03240.x, lire en ligne, consulté le )
A. Shechter, P. Lespérance, NM. Ng Ying Kin et DB. Boivin, « Pilot Investigation of the Circadian Plasma Melatonin Rhythm across the Menstrual Cycle in a Small Group of Women with Premenstrual Dysphoric Disorder. », PLoS One, vol. 7, no 12, , e51929 (PMID23284821, DOI10.1371/journal.pone.0051929, lire en ligne)
(en) Yadi Zhou, Yuan Hou, Jiayu Shen et Reena Mehra, « A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 », PLOS Biology, vol. 18, no 11, , e3000970 (ISSN1545-7885, DOI10.1371/journal.pbio.3000970, lire en ligne, consulté le )
Ye-min Wang, Bao-zhe Jin, Fang Ai et Chang-hong Duan, « The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials », Cancer Chemotherapy and Pharmacology, vol. 69, no 5, , p. 1213–1220 (ISSN1432-0843, PMID22271210, DOI10.1007/s00280-012-1828-8, lire en ligne, consulté le )
(en) Paolo Lissoni, Giorgio Porro, Carla Galli et Rosalia Codogni, « A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin », Trends in Oncology, vol. 2, no 2, , p. 1–5 (ISSN2717-5278, DOI10.37155/2717-5278-0202-1, lire en ligne, consulté le )
Ping-Tao Tseng, Chun-Pai Yang, Kuan-Pin Su et Tien-Yu Chen, « The association between melatonin and episodic migraine: A pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy », Journal of Pineal Research, vol. 69, no 2, , e12663 (ISSN1600-079X, PMID32347977, DOI10.1111/jpi.12663, lire en ligne, consulté le )
Alfonso Mansilla-Roselló, Jorge Hernández-Magdalena, Mireia Domínguez-Bastante et Carmen Olmedo-Martín, « A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit », Journal of Pineal Research, , e12845 (ISSN1600-079X, PMID36428216, DOI10.1111/jpi.12845, lire en ligne, consulté le )
Maria Consuelo Mura, Sebastiano Luridiana, Federico Farci et Maria Veronica Di Stefano, « Melatonin treatment in winter and spring and reproductive recovery in Sarda breed sheep », Animal Reproduction Science, vol. 185, , p. 104–108 (ISSN1873-2232, PMID28823418, DOI10.1016/j.anireprosci.2017.08.009, lire en ligne, consulté le )
Alfred J. Lewy, Jonathan S. Emens, Bryan J. Lefler et Krista Yuhas, « Melatonin entrains free-running blind people according to a physiological dose-response curve », Chronobiology International, vol. 22, no 6, , p. 1093–1106 (ISSN0742-0528, PMID16393710, DOI10.1080/07420520500398064, lire en ligne, consulté le )
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman et Shantel L. Duffy, « Safety of higher doses of melatonin in adults: A systematic review and meta-analysis », Journal of Pineal Research, vol. 72, no 2, , e12782 (ISSN1600-079X, PMID34923676, DOI10.1111/jpi.12782, lire en ligne, consulté le )
doi.org
Étude conduite par Philippe Froguel (laboratoire Génomique et physiologie moléculaire des maladies métaboliques ; CNRS/ Université Lille 2 Droit et Santé/ Institut Pasteur de Lille) et l'Imperial College London, en collaboration avec des équipes françaises, finlandaises et danoises, sur la base de l'analyse du génome de 23 000 personnes, publiée dans Nature Genetics en décembre 2008 (A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risks. N. Bouatia-Naji et al. ; Nature Genetics, numéro 41, pages 89–94, 2009, https://doi.org/10.1038/ng.277 ). Les résultats de cette étude ont été confirmés par deux autres études internationales publiées au même moment (CNRS).
(en) Russel J. Reiter, L.C. Manchester et Dun-xian Tan, « Melatonin in walnuts: Influence on levels of melatonin and total antioxidant capacity of blood », Nutrition, vol. 21, no 9, , p. 920–924 (DOI10.1016/j.nut.2005.02.005, lire en ligne, consulté le )
Rodolphe Beaud, Hydroarylation régiosélective d’indoles pour l’accès aux motifs 3 - arylindolines : études et applications d’une nouvelle réactivité de l’indole, Institut de Chimie Moléculaire et des Matériaux d'Orsay, Université Paris-Sud, (HALtel-01127058, présentation en ligne, lire en ligne [PDF]), p. 28.
harvard.edu
ui.adsabs.harvard.edu
Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S, « Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system », Ann NY Acad Sci, vol. 939, , p. 200–15. (PMID11462772, DOI10.1111/j.1749-6632.2001.tb03627.x, Bibcode2001NYASA.939..200R)
(en) REITER Russel J. ; DUN XIAN TAN ; BURKHARDT Susanne ; MANCHESTER Lucien C. ; Melatonin in plants, in Nutrition reviews ; 2001, Ed : International Life Sciences Institute ; vol. 59, no 9, p. 286-290 (47 ref.) ; ISSN 0029-6643 Fiche INIST CNRS.
issn.org
portal.issn.org
Alejandro Ibáñez-Costa, José Córdoba-Chacón, Manuel D. Gahete et Rhonda D. Kineman, « Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates », Endocrinology, vol. 156, no 3, , p. 1100–1110 (ISSN1945-7170, PMID25545385, PMCID4330310, DOI10.1210/en.2014-1819, lire en ligne, consulté le )
(en) José Cipolla-Neto et Fernanda Gaspar do Amaral, « Melatonin as a Hormone: New Physiological and Clinical Insights », Endocrine Reviews, vol. 39, no 6, , p. 990–1028 (ISSN0163-769X et 1945-7189, DOI10.1210/er.2018-00084, lire en ligne, consulté le )
(en) José Cipolla-Neto, Fernanda Gaspar Amaral, José Maria Soares, Jr et Camila Congentino Gallo, « The Crosstalk between Melatonin and Sex Steroid Hormones », Neuroendocrinology, vol. 112, no 2, , p. 115–129 (ISSN0028-3835 et 1423-0194, DOI10.1159/000516148, lire en ligne, consulté le )
Antonio Carrillo-Vico, Juan M. Guerrero, Patricia J. Lardone et Russel J. Reiter, « A review of the multiple actions of melatonin on the immune system », Endocrine, vol. 27, no 2, , p. 189–200 (ISSN1355-008X, PMID16217132, DOI10.1385/ENDO:27:2:189, lire en ligne, consulté le )
(en) Feixiong Cheng, « A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 », PLOS Biology, vol. 18, no 11, , e3000970 (ISSN1545-7885, DOI10.1371/journal.pbio.3000970, lire en ligne, consulté le ).
A. Lerchl et S. Schlatt, « Serotonin content and melatonin production in the pineal gland of the male Djungarian hamster (Phodopus sungorus) », Journal of Pineal Research, vol. 12, no 3, , p. 128–134 (ISSN0742-3098, PMID1380550, DOI10.1111/j.1600-079x.1992.tb00039.x, lire en ligne, consulté le )
Yalikun Suofu, Wei Li, Frédéric G. Jean-Alphonse et Jiaoying Jia, « Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release », Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no 38, , E7997–E8006 (ISSN0027-8424, PMID28874589, PMCID5617277, DOI10.1073/pnas.1705768114, lire en ligne, consulté le )
Russel J. Reiter, Dun Xian Tan, Sergio Rosales-Corral et Annia Galano, « Mitochondria: Central Organelles for Melatonin′s Antioxidant and Anti-Aging Actions », Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, vol. 23, no 2, , p. 509 (ISSN1420-3049, PMID29495303, PMCID6017324, DOI10.3390/molecules23020509, lire en ligne, consulté le )
Garth R. Swanson, Annika Gorenz, Maliha Shaikh et Vishal Desai, « Decreased melatonin secretion is associated with increased intestinal permeability and marker of endotoxemia in alcoholics », American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 308, no 12, , G1004–G1011 (ISSN0193-1857, PMID25907689, PMCID4469868, DOI10.1152/ajpgi.00002.2015, lire en ligne, consulté le )
Young Sook Park, Soo Hyung Kim, Jong Won Park et Younglim Kho, « Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation », Intestinal Research, vol. 18, no 3, , p. 325–336 (ISSN1598-9100, PMID32564539, PMCID7385569, DOI10.5217/ir.2019.00093, lire en ligne, consulté le )
Vennila Suriagandhi et Vasanthi Nachiappan, « Protective Effects of Melatonin against Obesity-Induced by Leptin Resistance », Behavioural Brain Research, vol. 417, , p. 113598 (ISSN1872-7549, PMID34563600, DOI10.1016/j.bbr.2021.113598, lire en ligne, consulté le )
Pilar Cano, Daniel P. Cardinali, María J. Ríos-Lugo et María P. Fernández-Mateos, « Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats », Obesity (Silver Spring, Md.), vol. 17, no 10, , p. 1866–1871 (ISSN1930-7381, PMID19543212, DOI10.1038/oby.2009.200, lire en ligne, consulté le )
Angeliki Karamitri, Nicolas Renault, Nathalie Clement et Jean-Luc Guillaume, « Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes », Molecular Endocrinology (Baltimore, Md.), vol. 27, no 8, , p. 1217–1233 (ISSN1944-9917, PMID23798576, PMCID5427945, DOI10.1210/me.2013-1101, lire en ligne, consulté le )
Alan Hegron et Ralf Jockers, « Analyse approfondie du lien entre le récepteur MT2 de la mélatonine et le diabète de type 2 », médecine/sciences, vol. 35, no 5, , p. 412–416 (ISSN0767-0974 et 1958-5381, DOI10.1051/medsci/2019088, lire en ligne, consulté le )
(en) Dun-Xian Tan, Lucien C. Manchester, Maria P. Terron et Luis J. Flores, « One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species? », Journal of Pineal Research, vol. 42, no 1, , p. 28–42 (ISSN0742-3098 et 1600-079X, DOI10.1111/j.1600-079X.2006.00407.x, lire en ligne, consulté le )
Jerry Vriend et Russel J. Reiter, « The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome », Molecular and Cellular Endocrinology, vol. 401, , p. 213–220 (ISSN1872-8057, PMID25528518, DOI10.1016/j.mce.2014.12.013, lire en ligne, consulté le )
K. P. Wright, B. L. Myers, S. C. Plenzler et C. L. Drake, « Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives », Brain Research, vol. 873, no 2, , p. 310–317 (ISSN0006-8993, PMID10930561, DOI10.1016/s0006-8993(00)02557-9, lire en ligne, consulté le )
Kathleen E. West, Michael R. Jablonski, Benjamin Warfield et Kate S. Cecil, « Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans », Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 110, no 3, , p. 619–626 (ISSN1522-1601, PMID21164152, DOI10.1152/japplphysiol.01413.2009, lire en ligne, consulté le )
Mariana G. Figueiro et Mark S. Rea, « The Effects of Red and Blue Lights on Circadian Variations in Cortisol, Alpha Amylase, and Melatonin », International Journal of Endocrinology, vol. 2010, , p. 829351 (ISSN1687-8337, PMID20652045, PMCID2905913, DOI10.1155/2010/829351, lire en ligne, consulté le )
Olga Pechanova, Ludovit Paulis et Fedor Simko, « Peripheral and central effects of melatonin on blood pressure regulation », International Journal of Molecular Sciences, vol. 15, no 10, , p. 17920–17937 (ISSN1422-0067, PMID25299692, PMCID4227197, DOI10.3390/ijms151017920, lire en ligne, consulté le )
Huanshuai Guan, Ning Kong, Run Tian et Ruomu Cao, « Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis », Journal of Translational Medicine, vol. 20, no 1, , p. 132 (ISSN1479-5876, PMID35296324, PMCID8925213, DOI10.1186/s12967-022-03341-7, lire en ligne, consulté le )
Tian Li, Shuai Jiang, Chenxi Lu et Wenwen Yang, « Melatonin: Another avenue for treating osteoporosis? », Journal of Pineal Research, vol. 66, no 2, , e12548 (ISSN1600-079X, PMID30597617, DOI10.1111/jpi.12548, lire en ligne, consulté le )
Fahima Munmun et Paula A. Witt-Enderby, « Melatonin effects on bone: Implications for use as a therapy for managing bone loss », Journal of Pineal Research, vol. 71, no 1, , e12749 (ISSN1600-079X, PMID34085304, DOI10.1111/jpi.12749, lire en ligne, consulté le )
José Carlos Pereira, Márcia Pradella Hallinan et Rosana Cardoso Alves, « Secondary to excessive melatonin synthesis, the consumption of tryptophan from outside the blood-brain barrier and melatonin over-signaling in the pars tuberalis may be central to the pathophysiology of winter depression », Medical Hypotheses, vol. 98, , p. 69–75 (ISSN1532-2777, PMID28012610, DOI10.1016/j.mehy.2016.11.020, lire en ligne, consulté le )
Maria E. J. Bouwmans, Elisabeth H. Bos, Sanne H. Booij et Martijn van Faassen, « Intra- and inter-individual variability of longitudinal daytime melatonin secretion patterns in depressed and non-depressed individuals », Chronobiology International, vol. 32, no 3, , p. 441–446 (ISSN1525-6073, PMID25347155, DOI10.3109/07420528.2014.973114, lire en ligne, consulté le )
Barbara Nussbaumer-Streit, Amy Greenblatt, Angela Kaminski-Hartenthaler et Megan G. Van Noord, « Melatonin and agomelatine for preventing seasonal affective disorder », The Cochrane Database of Systematic Reviews, vol. 6, no 6, , p. CD011271 (ISSN1469-493X, PMID31206585, PMCID6578031, DOI10.1002/14651858.CD011271.pub3, lire en ligne, consulté le )
(en) Maria D. Maldonado, Russel J. Reiter et Maria A. Pérez-San-Gregorio, « Melatonin as a potential therapeutic agent in psychiatric illness », Human Psychopharmacology: Clinical and Experimental, vol. 24, no 5, , p. 391–400 (ISSN1099-1077, DOI10.1002/hup.1032, lire en ligne, consulté le )
George Anderson et Michael Maes, « Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects », Metabolic Brain Disease, vol. 27, no 2, , p. 113–119 (ISSN1573-7365, PMID22527998, DOI10.1007/s11011-012-9307-9, lire en ligne, consulté le )
Yunho Jin, Jeonghyun Choi, Seunghoon Lee et Jong Won Kim, « Pathogenetical and Neurophysiological Features of Patients with Autism Spectrum Disorder: Phenomena and Diagnoses », Journal of Clinical Medicine, vol. 8, no 10, , p. 1588 (ISSN2077-0383, PMID31581672, PMCID6832208, DOI10.3390/jcm8101588, lire en ligne, consulté le )
M. L. Rao, B. Müller-Oerlinghausen, A. Mackert et B. Strebel, « Blood serotonin, serum melatonin and light therapy in healthy subjects and in patients with nonseasonal depression », Acta Psychiatrica Scandinavica, vol. 86, no 2, , p. 127–132 (ISSN0001-690X, PMID1529735, DOI10.1111/j.1600-0447.1992.tb03240.x, lire en ligne, consulté le )
(en) Yadi Zhou, Yuan Hou, Jiayu Shen et Reena Mehra, « A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 », PLOS Biology, vol. 18, no 11, , e3000970 (ISSN1545-7885, DOI10.1371/journal.pbio.3000970, lire en ligne, consulté le )
Ye-min Wang, Bao-zhe Jin, Fang Ai et Chang-hong Duan, « The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials », Cancer Chemotherapy and Pharmacology, vol. 69, no 5, , p. 1213–1220 (ISSN1432-0843, PMID22271210, DOI10.1007/s00280-012-1828-8, lire en ligne, consulté le )
(en) Paolo Lissoni, Giorgio Porro, Carla Galli et Rosalia Codogni, « A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin », Trends in Oncology, vol. 2, no 2, , p. 1–5 (ISSN2717-5278, DOI10.37155/2717-5278-0202-1, lire en ligne, consulté le )
Ping-Tao Tseng, Chun-Pai Yang, Kuan-Pin Su et Tien-Yu Chen, « The association between melatonin and episodic migraine: A pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy », Journal of Pineal Research, vol. 69, no 2, , e12663 (ISSN1600-079X, PMID32347977, DOI10.1111/jpi.12663, lire en ligne, consulté le )
Alfonso Mansilla-Roselló, Jorge Hernández-Magdalena, Mireia Domínguez-Bastante et Carmen Olmedo-Martín, « A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit », Journal of Pineal Research, , e12845 (ISSN1600-079X, PMID36428216, DOI10.1111/jpi.12845, lire en ligne, consulté le )
Maria Consuelo Mura, Sebastiano Luridiana, Federico Farci et Maria Veronica Di Stefano, « Melatonin treatment in winter and spring and reproductive recovery in Sarda breed sheep », Animal Reproduction Science, vol. 185, , p. 104–108 (ISSN1873-2232, PMID28823418, DOI10.1016/j.anireprosci.2017.08.009, lire en ligne, consulté le )
Alfred J. Lewy, Jonathan S. Emens, Bryan J. Lefler et Krista Yuhas, « Melatonin entrains free-running blind people according to a physiological dose-response curve », Chronobiology International, vol. 22, no 6, , p. 1093–1106 (ISSN0742-0528, PMID16393710, DOI10.1080/07420520500398064, lire en ligne, consulté le )
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman et Shantel L. Duffy, « Safety of higher doses of melatonin in adults: A systematic review and meta-analysis », Journal of Pineal Research, vol. 72, no 2, , e12782 (ISSN1600-079X, PMID34923676, DOI10.1111/jpi.12782, lire en ligne, consulté le )
jamanetwork.com
jama.jamanetwork.com
(en) Rixt F. Riemersma-van der Lek, Dick F. Swaab, Jos Twisk, Elly M. Hol, Witte J. G. Hoogendijk, Eus J. W. Van Someren, « 'Effect of bright light and melatonin on cognitive and non cognitive function of elderly residents of group care facilities. A randomized controlled trial », Journal of the American Medical Association (JAMA), vol. 229, no 22, , p. 2642-2655 (résumé).
karger.com
(en) José Cipolla-Neto, Fernanda Gaspar Amaral, José Maria Soares, Jr et Camila Congentino Gallo, « The Crosstalk between Melatonin and Sex Steroid Hormones », Neuroendocrinology, vol. 112, no 2, , p. 115–129 (ISSN0028-3835 et 1423-0194, DOI10.1159/000516148, lire en ligne, consulté le )
lefigaro.fr
sante.lefigaro.fr
Damien Mascret, « La mélatonine encore en vente libre malgré l'interdiction », Le Figaro - Santé, (lire en ligne)
Alan Hegron et Ralf Jockers, « Analyse approfondie du lien entre le récepteur MT2 de la mélatonine et le diabète de type 2 », médecine/sciences, vol. 35, no 5, , p. 412–416 (ISSN0767-0974 et 1958-5381, DOI10.1051/medsci/2019088, lire en ligne, consulté le )
Alejandro Ibáñez-Costa, José Córdoba-Chacón, Manuel D. Gahete et Rhonda D. Kineman, « Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates », Endocrinology, vol. 156, no 3, , p. 1100–1110 (ISSN1945-7170, PMID25545385, PMCID4330310, DOI10.1210/en.2014-1819, lire en ligne, consulté le )
(en) Hardeland R, « Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance », Endocrine, vol. 27, no 2, , p. 119–30. (PMID16217125, DOI10.1385/ENDO:27:2:119)
Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S, « Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system », Ann NY Acad Sci, vol. 939, , p. 200–15. (PMID11462772, DOI10.1111/j.1749-6632.2001.tb03627.x, Bibcode2001NYASA.939..200R)
Antonio Carrillo-Vico, Juan M. Guerrero, Patricia J. Lardone et Russel J. Reiter, « A review of the multiple actions of melatonin on the immune system », Endocrine, vol. 27, no 2, , p. 189–200 (ISSN1355-008X, PMID16217132, DOI10.1385/ENDO:27:2:189, lire en ligne, consulté le )
(en) Caniato R, Filippini R, Piovan A, Puricelli L, Borsarini A, Cappelletti E. « Melatonin in plants » Adv Exp Med Biol. 2003;527:593–7. PMID15206778
(en) Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ, « Phytomelatonin: a review », J Exp Bot, vol. 60, no 1, , p. 57–69 (PMID19033551, DOI10.1093/jxb/ern284)
A. Lerchl et S. Schlatt, « Serotonin content and melatonin production in the pineal gland of the male Djungarian hamster (Phodopus sungorus) », Journal of Pineal Research, vol. 12, no 3, , p. 128–134 (ISSN0742-3098, PMID1380550, DOI10.1111/j.1600-079x.1992.tb00039.x, lire en ligne, consulté le )
Yalikun Suofu, Wei Li, Frédéric G. Jean-Alphonse et Jiaoying Jia, « Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release », Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no 38, , E7997–E8006 (ISSN0027-8424, PMID28874589, PMCID5617277, DOI10.1073/pnas.1705768114, lire en ligne, consulté le )
Russel J. Reiter, Dun Xian Tan, Sergio Rosales-Corral et Annia Galano, « Mitochondria: Central Organelles for Melatonin′s Antioxidant and Anti-Aging Actions », Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, vol. 23, no 2, , p. 509 (ISSN1420-3049, PMID29495303, PMCID6017324, DOI10.3390/molecules23020509, lire en ligne, consulté le )
(en) Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ, « Phytomelatonin : a review », J. Exp. Bot., vol. 60, no 1, , p. 57–69 (PMID19033551, DOI10.1093/jxb/ern284, lire en ligne).
Garth R. Swanson, Annika Gorenz, Maliha Shaikh et Vishal Desai, « Decreased melatonin secretion is associated with increased intestinal permeability and marker of endotoxemia in alcoholics », American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 308, no 12, , G1004–G1011 (ISSN0193-1857, PMID25907689, PMCID4469868, DOI10.1152/ajpgi.00002.2015, lire en ligne, consulté le )
Young Sook Park, Soo Hyung Kim, Jong Won Park et Younglim Kho, « Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation », Intestinal Research, vol. 18, no 3, , p. 325–336 (ISSN1598-9100, PMID32564539, PMCID7385569, DOI10.5217/ir.2019.00093, lire en ligne, consulté le )
Vennila Suriagandhi et Vasanthi Nachiappan, « Protective Effects of Melatonin against Obesity-Induced by Leptin Resistance », Behavioural Brain Research, vol. 417, , p. 113598 (ISSN1872-7549, PMID34563600, DOI10.1016/j.bbr.2021.113598, lire en ligne, consulté le )
Pilar Cano, Daniel P. Cardinali, María J. Ríos-Lugo et María P. Fernández-Mateos, « Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats », Obesity (Silver Spring, Md.), vol. 17, no 10, , p. 1866–1871 (ISSN1930-7381, PMID19543212, DOI10.1038/oby.2009.200, lire en ligne, consulté le )
Angeliki Karamitri, Nicolas Renault, Nathalie Clement et Jean-Luc Guillaume, « Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes », Molecular Endocrinology (Baltimore, Md.), vol. 27, no 8, , p. 1217–1233 (ISSN1944-9917, PMID23798576, PMCID5427945, DOI10.1210/me.2013-1101, lire en ligne, consulté le )
(en) Akcay YD, Yalcin A, Sozmen EY, « The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid-induced injury », Cell. Mol. Biol. Lett., vol. 10, no 2, , p. 321–9 (PMID16010296, lire en ligne [PDF]).
(en) Cucina A, Proietti S, D'Anselmi F, Coluccia P, Dinicola S, Frati L, Bizzarri M., Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells ; J Pineal Res. 2009 Mar; 46(2):172-80. Epub 2008 Oct 29 (Résumé)
(en) Sánchez-Barceló EJ, Cos S, Fernández R, Mediavilla MD. , Melatonin and mammary cancer: a short review, Endocr Relat Cancer, juin 2003, 10(2):153-9. (Résumé)
Jerry Vriend et Russel J. Reiter, « The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome », Molecular and Cellular Endocrinology, vol. 401, , p. 213–220 (ISSN1872-8057, PMID25528518, DOI10.1016/j.mce.2014.12.013, lire en ligne, consulté le )
(en) Vasin MV, Ushakov IB, Suvorov NN. « Radioprotective effectiveness of indralin in local gamma irradiation of the skin » Radiats Biol Radioecol. 1998 Jan-Feb; 38(1):42-54. (Résumé)
(en) Vasin MV, Ushakov IB, Kovtun VIu, Komarova SN, Semenova LA, Galkin AA. « Comparative effectiveness of antioxidant melatonin and radioprotectors indralin and phenylephrine in local radiation injuries » Radiats Biol Radioecol. 2004;44(1):68-71. Article en Russe, Résumé en anglais, Source Institute of Military Medicine, Ministry of Deferense of Russian Federation, 126083 Russia
FA. Scheer, CJ. Morris, JI. Garcia, C. Smales, EE. Kelly, J. Marks, A. Malhotra et SA. Shea, « Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. », Sleep, vol. 35, no 10, , p. 1395-402 (PMID23024438, DOI10.5665/sleep.2122)
K. P. Wright, B. L. Myers, S. C. Plenzler et C. L. Drake, « Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives », Brain Research, vol. 873, no 2, , p. 310–317 (ISSN0006-8993, PMID10930561, DOI10.1016/s0006-8993(00)02557-9, lire en ligne, consulté le )
Kathleen E. West, Michael R. Jablonski, Benjamin Warfield et Kate S. Cecil, « Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans », Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 110, no 3, , p. 619–626 (ISSN1522-1601, PMID21164152, DOI10.1152/japplphysiol.01413.2009, lire en ligne, consulté le )
Mariana G. Figueiro et Mark S. Rea, « The Effects of Red and Blue Lights on Circadian Variations in Cortisol, Alpha Amylase, and Melatonin », International Journal of Endocrinology, vol. 2010, , p. 829351 (ISSN1687-8337, PMID20652045, PMCID2905913, DOI10.1155/2010/829351, lire en ligne, consulté le )
Olga Pechanova, Ludovit Paulis et Fedor Simko, « Peripheral and central effects of melatonin on blood pressure regulation », International Journal of Molecular Sciences, vol. 15, no 10, , p. 17920–17937 (ISSN1422-0067, PMID25299692, PMCID4227197, DOI10.3390/ijms151017920, lire en ligne, consulté le )
Huanshuai Guan, Ning Kong, Run Tian et Ruomu Cao, « Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis », Journal of Translational Medicine, vol. 20, no 1, , p. 132 (ISSN1479-5876, PMID35296324, PMCID8925213, DOI10.1186/s12967-022-03341-7, lire en ligne, consulté le )
Tian Li, Shuai Jiang, Chenxi Lu et Wenwen Yang, « Melatonin: Another avenue for treating osteoporosis? », Journal of Pineal Research, vol. 66, no 2, , e12548 (ISSN1600-079X, PMID30597617, DOI10.1111/jpi.12548, lire en ligne, consulté le )
Fahima Munmun et Paula A. Witt-Enderby, « Melatonin effects on bone: Implications for use as a therapy for managing bone loss », Journal of Pineal Research, vol. 71, no 1, , e12749 (ISSN1600-079X, PMID34085304, DOI10.1111/jpi.12749, lire en ligne, consulté le )
José Carlos Pereira, Márcia Pradella Hallinan et Rosana Cardoso Alves, « Secondary to excessive melatonin synthesis, the consumption of tryptophan from outside the blood-brain barrier and melatonin over-signaling in the pars tuberalis may be central to the pathophysiology of winter depression », Medical Hypotheses, vol. 98, , p. 69–75 (ISSN1532-2777, PMID28012610, DOI10.1016/j.mehy.2016.11.020, lire en ligne, consulté le )
Maria E. J. Bouwmans, Elisabeth H. Bos, Sanne H. Booij et Martijn van Faassen, « Intra- and inter-individual variability of longitudinal daytime melatonin secretion patterns in depressed and non-depressed individuals », Chronobiology International, vol. 32, no 3, , p. 441–446 (ISSN1525-6073, PMID25347155, DOI10.3109/07420528.2014.973114, lire en ligne, consulté le )
Barbara Nussbaumer-Streit, Amy Greenblatt, Angela Kaminski-Hartenthaler et Megan G. Van Noord, « Melatonin and agomelatine for preventing seasonal affective disorder », The Cochrane Database of Systematic Reviews, vol. 6, no 6, , p. CD011271 (ISSN1469-493X, PMID31206585, PMCID6578031, DOI10.1002/14651858.CD011271.pub3, lire en ligne, consulté le )
George Anderson et Michael Maes, « Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects », Metabolic Brain Disease, vol. 27, no 2, , p. 113–119 (ISSN1573-7365, PMID22527998, DOI10.1007/s11011-012-9307-9, lire en ligne, consulté le )
Yunho Jin, Jeonghyun Choi, Seunghoon Lee et Jong Won Kim, « Pathogenetical and Neurophysiological Features of Patients with Autism Spectrum Disorder: Phenomena and Diagnoses », Journal of Clinical Medicine, vol. 8, no 10, , p. 1588 (ISSN2077-0383, PMID31581672, PMCID6832208, DOI10.3390/jcm8101588, lire en ligne, consulté le )
M. L. Rao, B. Müller-Oerlinghausen, A. Mackert et B. Strebel, « Blood serotonin, serum melatonin and light therapy in healthy subjects and in patients with nonseasonal depression », Acta Psychiatrica Scandinavica, vol. 86, no 2, , p. 127–132 (ISSN0001-690X, PMID1529735, DOI10.1111/j.1600-0447.1992.tb03240.x, lire en ligne, consulté le )
A. Shechter, P. Lespérance, NM. Ng Ying Kin et DB. Boivin, « Pilot Investigation of the Circadian Plasma Melatonin Rhythm across the Menstrual Cycle in a Small Group of Women with Premenstrual Dysphoric Disorder. », PLoS One, vol. 7, no 12, , e51929 (PMID23284821, DOI10.1371/journal.pone.0051929, lire en ligne)
Ye-min Wang, Bao-zhe Jin, Fang Ai et Chang-hong Duan, « The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials », Cancer Chemotherapy and Pharmacology, vol. 69, no 5, , p. 1213–1220 (ISSN1432-0843, PMID22271210, DOI10.1007/s00280-012-1828-8, lire en ligne, consulté le )
Ping-Tao Tseng, Chun-Pai Yang, Kuan-Pin Su et Tien-Yu Chen, « The association between melatonin and episodic migraine: A pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy », Journal of Pineal Research, vol. 69, no 2, , e12663 (ISSN1600-079X, PMID32347977, DOI10.1111/jpi.12663, lire en ligne, consulté le )
Alfonso Mansilla-Roselló, Jorge Hernández-Magdalena, Mireia Domínguez-Bastante et Carmen Olmedo-Martín, « A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit », Journal of Pineal Research, , e12845 (ISSN1600-079X, PMID36428216, DOI10.1111/jpi.12845, lire en ligne, consulté le )
(en) Zhdanova I, Wurtman R, Regan M, Taylor J, Shi J, Leclair O. « Melatonin treatment for age-related insomnia » J Clin Endocrinol Metab. 2001;86(10) p. 4727-30PMID11600532
(en) Lewy AJ, Emens JS, Sack RL, Hasler BP, Bernert RA. « Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period »Chronobiol Int. 2002;19, 3, p. 649-58, PMID12069043
(en) Wolkove N, Elkholy O, Baltzan M, Palayew M, « Sleep and aging : 2. Management of sleep disorders in older people » CMAJ : Canadian Medical Association Journal - Journal de l'Association médicale canadienne 2007, volume 176, no 10, p. 1449-54PMID17485699
(en) McGechan A, Wellington K. « Ramelteon » CNS Drugs 2005;19:1057-65; discussion 1066-7. PMID16332146
Pintor J, Peláez T, Hoyle CH, Peral A. « Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor » Br J Pharmacol. 2003 Mar;138(5):831-6. (Résumé)
(en) Andrés-Guerrero V, Alarma-Estrany P, Molina-Martínez IT, Peral A, Herrero-Vanrell R, Pintor « Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT » J Exp Eye Res. 2009 Mar; 88(3):504-11. Epub 2008 Nov 14. (Résumé)
Maria Consuelo Mura, Sebastiano Luridiana, Federico Farci et Maria Veronica Di Stefano, « Melatonin treatment in winter and spring and reproductive recovery in Sarda breed sheep », Animal Reproduction Science, vol. 185, , p. 104–108 (ISSN1873-2232, PMID28823418, DOI10.1016/j.anireprosci.2017.08.009, lire en ligne, consulté le )
Alfred J. Lewy, Jonathan S. Emens, Bryan J. Lefler et Krista Yuhas, « Melatonin entrains free-running blind people according to a physiological dose-response curve », Chronobiology International, vol. 22, no 6, , p. 1093–1106 (ISSN0742-0528, PMID16393710, DOI10.1080/07420520500398064, lire en ligne, consulté le )
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman et Shantel L. Duffy, « Safety of higher doses of melatonin in adults: A systematic review and meta-analysis », Journal of Pineal Research, vol. 72, no 2, , e12782 (ISSN1600-079X, PMID34923676, DOI10.1111/jpi.12782, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
Alejandro Ibáñez-Costa, José Córdoba-Chacón, Manuel D. Gahete et Rhonda D. Kineman, « Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates », Endocrinology, vol. 156, no 3, , p. 1100–1110 (ISSN1945-7170, PMID25545385, PMCID4330310, DOI10.1210/en.2014-1819, lire en ligne, consulté le )
Antonio Carrillo-Vico, Juan M. Guerrero, Patricia J. Lardone et Russel J. Reiter, « A review of the multiple actions of melatonin on the immune system », Endocrine, vol. 27, no 2, , p. 189–200 (ISSN1355-008X, PMID16217132, DOI10.1385/ENDO:27:2:189, lire en ligne, consulté le )
A. Lerchl et S. Schlatt, « Serotonin content and melatonin production in the pineal gland of the male Djungarian hamster (Phodopus sungorus) », Journal of Pineal Research, vol. 12, no 3, , p. 128–134 (ISSN0742-3098, PMID1380550, DOI10.1111/j.1600-079x.1992.tb00039.x, lire en ligne, consulté le )
Vennila Suriagandhi et Vasanthi Nachiappan, « Protective Effects of Melatonin against Obesity-Induced by Leptin Resistance », Behavioural Brain Research, vol. 417, , p. 113598 (ISSN1872-7549, PMID34563600, DOI10.1016/j.bbr.2021.113598, lire en ligne, consulté le )
Pilar Cano, Daniel P. Cardinali, María J. Ríos-Lugo et María P. Fernández-Mateos, « Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats », Obesity (Silver Spring, Md.), vol. 17, no 10, , p. 1866–1871 (ISSN1930-7381, PMID19543212, DOI10.1038/oby.2009.200, lire en ligne, consulté le )
Angeliki Karamitri, Nicolas Renault, Nathalie Clement et Jean-Luc Guillaume, « Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes », Molecular Endocrinology (Baltimore, Md.), vol. 27, no 8, , p. 1217–1233 (ISSN1944-9917, PMID23798576, PMCID5427945, DOI10.1210/me.2013-1101, lire en ligne, consulté le )
Jerry Vriend et Russel J. Reiter, « The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome », Molecular and Cellular Endocrinology, vol. 401, , p. 213–220 (ISSN1872-8057, PMID25528518, DOI10.1016/j.mce.2014.12.013, lire en ligne, consulté le )
K. P. Wright, B. L. Myers, S. C. Plenzler et C. L. Drake, « Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives », Brain Research, vol. 873, no 2, , p. 310–317 (ISSN0006-8993, PMID10930561, DOI10.1016/s0006-8993(00)02557-9, lire en ligne, consulté le )
Kathleen E. West, Michael R. Jablonski, Benjamin Warfield et Kate S. Cecil, « Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans », Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 110, no 3, , p. 619–626 (ISSN1522-1601, PMID21164152, DOI10.1152/japplphysiol.01413.2009, lire en ligne, consulté le )
Olga Pechanova, Ludovit Paulis et Fedor Simko, « Peripheral and central effects of melatonin on blood pressure regulation », International Journal of Molecular Sciences, vol. 15, no 10, , p. 17920–17937 (ISSN1422-0067, PMID25299692, PMCID4227197, DOI10.3390/ijms151017920, lire en ligne, consulté le )
Huanshuai Guan, Ning Kong, Run Tian et Ruomu Cao, « Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis », Journal of Translational Medicine, vol. 20, no 1, , p. 132 (ISSN1479-5876, PMID35296324, PMCID8925213, DOI10.1186/s12967-022-03341-7, lire en ligne, consulté le )
Tian Li, Shuai Jiang, Chenxi Lu et Wenwen Yang, « Melatonin: Another avenue for treating osteoporosis? », Journal of Pineal Research, vol. 66, no 2, , e12548 (ISSN1600-079X, PMID30597617, DOI10.1111/jpi.12548, lire en ligne, consulté le )
Fahima Munmun et Paula A. Witt-Enderby, « Melatonin effects on bone: Implications for use as a therapy for managing bone loss », Journal of Pineal Research, vol. 71, no 1, , e12749 (ISSN1600-079X, PMID34085304, DOI10.1111/jpi.12749, lire en ligne, consulté le )
José Carlos Pereira, Márcia Pradella Hallinan et Rosana Cardoso Alves, « Secondary to excessive melatonin synthesis, the consumption of tryptophan from outside the blood-brain barrier and melatonin over-signaling in the pars tuberalis may be central to the pathophysiology of winter depression », Medical Hypotheses, vol. 98, , p. 69–75 (ISSN1532-2777, PMID28012610, DOI10.1016/j.mehy.2016.11.020, lire en ligne, consulté le )
Maria E. J. Bouwmans, Elisabeth H. Bos, Sanne H. Booij et Martijn van Faassen, « Intra- and inter-individual variability of longitudinal daytime melatonin secretion patterns in depressed and non-depressed individuals », Chronobiology International, vol. 32, no 3, , p. 441–446 (ISSN1525-6073, PMID25347155, DOI10.3109/07420528.2014.973114, lire en ligne, consulté le )
Barbara Nussbaumer-Streit, Amy Greenblatt, Angela Kaminski-Hartenthaler et Megan G. Van Noord, « Melatonin and agomelatine for preventing seasonal affective disorder », The Cochrane Database of Systematic Reviews, vol. 6, no 6, , p. CD011271 (ISSN1469-493X, PMID31206585, PMCID6578031, DOI10.1002/14651858.CD011271.pub3, lire en ligne, consulté le )
(en) Maria D. Maldonado, Russel J. Reiter et Maria A. Pérez-San-Gregorio, « Melatonin as a potential therapeutic agent in psychiatric illness », Human Psychopharmacology: Clinical and Experimental, vol. 24, no 5, , p. 391–400 (ISSN1099-1077, DOI10.1002/hup.1032, lire en ligne, consulté le )
George Anderson et Michael Maes, « Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects », Metabolic Brain Disease, vol. 27, no 2, , p. 113–119 (ISSN1573-7365, PMID22527998, DOI10.1007/s11011-012-9307-9, lire en ligne, consulté le )
Yunho Jin, Jeonghyun Choi, Seunghoon Lee et Jong Won Kim, « Pathogenetical and Neurophysiological Features of Patients with Autism Spectrum Disorder: Phenomena and Diagnoses », Journal of Clinical Medicine, vol. 8, no 10, , p. 1588 (ISSN2077-0383, PMID31581672, PMCID6832208, DOI10.3390/jcm8101588, lire en ligne, consulté le )
M. L. Rao, B. Müller-Oerlinghausen, A. Mackert et B. Strebel, « Blood serotonin, serum melatonin and light therapy in healthy subjects and in patients with nonseasonal depression », Acta Psychiatrica Scandinavica, vol. 86, no 2, , p. 127–132 (ISSN0001-690X, PMID1529735, DOI10.1111/j.1600-0447.1992.tb03240.x, lire en ligne, consulté le )
Ye-min Wang, Bao-zhe Jin, Fang Ai et Chang-hong Duan, « The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials », Cancer Chemotherapy and Pharmacology, vol. 69, no 5, , p. 1213–1220 (ISSN1432-0843, PMID22271210, DOI10.1007/s00280-012-1828-8, lire en ligne, consulté le )
Ping-Tao Tseng, Chun-Pai Yang, Kuan-Pin Su et Tien-Yu Chen, « The association between melatonin and episodic migraine: A pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy », Journal of Pineal Research, vol. 69, no 2, , e12663 (ISSN1600-079X, PMID32347977, DOI10.1111/jpi.12663, lire en ligne, consulté le )
Alfonso Mansilla-Roselló, Jorge Hernández-Magdalena, Mireia Domínguez-Bastante et Carmen Olmedo-Martín, « A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit », Journal of Pineal Research, , e12845 (ISSN1600-079X, PMID36428216, DOI10.1111/jpi.12845, lire en ligne, consulté le )
Maria Consuelo Mura, Sebastiano Luridiana, Federico Farci et Maria Veronica Di Stefano, « Melatonin treatment in winter and spring and reproductive recovery in Sarda breed sheep », Animal Reproduction Science, vol. 185, , p. 104–108 (ISSN1873-2232, PMID28823418, DOI10.1016/j.anireprosci.2017.08.009, lire en ligne, consulté le )
Alfred J. Lewy, Jonathan S. Emens, Bryan J. Lefler et Krista Yuhas, « Melatonin entrains free-running blind people according to a physiological dose-response curve », Chronobiology International, vol. 22, no 6, , p. 1093–1106 (ISSN0742-0528, PMID16393710, DOI10.1080/07420520500398064, lire en ligne, consulté le )
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman et Shantel L. Duffy, « Safety of higher doses of melatonin in adults: A systematic review and meta-analysis », Journal of Pineal Research, vol. 72, no 2, , e12782 (ISSN1600-079X, PMID34923676, DOI10.1111/jpi.12782, lire en ligne, consulté le )
omniscient.sg
ojs.omniscient.sg
(en) Paolo Lissoni, Giorgio Porro, Carla Galli et Rosalia Codogni, « A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin », Trends in Oncology, vol. 2, no 2, , p. 1–5 (ISSN2717-5278, DOI10.37155/2717-5278-0202-1, lire en ligne, consulté le )
oup.com
academic.oup.com
(en) José Cipolla-Neto et Fernanda Gaspar do Amaral, « Melatonin as a Hormone: New Physiological and Clinical Insights », Endocrine Reviews, vol. 39, no 6, , p. 990–1028 (ISSN0163-769X et 1945-7189, DOI10.1210/er.2018-00084, lire en ligne, consulté le )
oxfordjournals.org
jxb.oxfordjournals.org
(en) Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ, « Phytomelatonin : a review », J. Exp. Bot., vol. 60, no 1, , p. 57–69 (PMID19033551, DOI10.1093/jxb/ern284, lire en ligne).
(en) Feixiong Cheng, « A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 », PLOS Biology, vol. 18, no 11, , e3000970 (ISSN1545-7885, DOI10.1371/journal.pbio.3000970, lire en ligne, consulté le ).
dx.plos.org
(en) Yadi Zhou, Yuan Hou, Jiayu Shen et Reena Mehra, « A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 », PLOS Biology, vol. 18, no 11, , e3000970 (ISSN1545-7885, DOI10.1371/journal.pbio.3000970, lire en ligne, consulté le )
plosone.org
A. Shechter, P. Lespérance, NM. Ng Ying Kin et DB. Boivin, « Pilot Investigation of the Circadian Plasma Melatonin Rhythm across the Menstrual Cycle in a Small Group of Women with Premenstrual Dysphoric Disorder. », PLoS One, vol. 7, no 12, , e51929 (PMID23284821, DOI10.1371/journal.pone.0051929, lire en ligne)
(en) L.A. Brotto et B.B. Gorzalka, « Melatonin enhances sexual behavior in the male rat », Physiology & Behavior, vol. 68, no 4, , p. 483–486 (résumé).
(en)Yi Zhanga, « Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis », Neurobiology of Disease, vol. 55, 2013, Pages 26–35 résumé en ligne
Basile M, Romeo C, Gitto E, Spitz L, Pierro A, Eaton S, Melatonin protects from, but does not reverse, the effects of mediators of sepsis on liver bioenergetics ; Journal : Pediatric Surgery International ; 2004, p. 263-266 (Résumé)
universalis.fr
Encyclopædia Universalis, « MÉLATONINE », sur Encyclopædia Universalis (consulté le )
(en) Carmen Venegas, José A. García, Germaine Escames et Francisco Ortiz, « Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations: Brain and liver extrapineal melatonin distribution », Journal of Pineal Research, vol. 52, no 2, , p. 217–227 (DOI10.1111/j.1600-079X.2011.00931.x, lire en ligne, consulté le )
(en) Andries Kalsbeek et al. (2000), « Melatonin sees the light: blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin » European Journal of Neuroscience vol. 12, no 9, pages 3146–3154, septembre 2000 ; DOI10.1046/j.1460-9568.2000.00202.x (résumé)
(en) Dun-Xian Tan, Lucien C. Manchester, Maria P. Terron et Luis J. Flores, « One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species? », Journal of Pineal Research, vol. 42, no 1, , p. 28–42 (ISSN0742-3098 et 1600-079X, DOI10.1111/j.1600-079X.2006.00407.x, lire en ligne, consulté le )
(en) Isaac Antolín, Barbara Obst, Susanne Burkhardt et Rüdiger Hardeland, « Antioxidative protection in a high-melatonin organism: the dinoflagellate Gonyaulax polyedra is rescued from lethal oxydative stress by strongly elevated, but physiologically possible concentrations of melatonin », Journal of Pineal Research, vol. 23, no 4, , p. 182–190 (résumé).
(en) Juan R. Calvo, C. González-Yanes et M. D. Maldonado, « The role of melatonin in the cells of the innate immunity: a review », Journal of Pineal Research, vol. 55, no 2, , p. 103–120 (DOI10.1111/jpi.12075, lire en ligne, consulté le )